简体
简体中文
繁體中文

Genter Capital股利收益主动型ETF GEND

等待开盘 08-17 09:30:00 美东时间

13.4739

0.000

0.00%

华盛通华盛通
立即下载
  • 最 高--
  • 今 开--
  • 成交量 0股
  • 最 低 --
  • 昨 收 13.4739
  • 总市值 498.53万
  • 52周最高 13.6562
  • 市盈率 --
  • 换手率 0.00%
  • 52周最低 10.7676
  • 委 比 0.00%
  • 总股本 37.00万
  • 历史最高 13.6562
  • 量 比 0
  • 振 幅 0.00%
  • 历史最低 8.7266
  • 每 手 1
  • 风险率 0.81%

个股概要

财务分析

公司资料

相关新闻

分红派息

  • 分时图
  • 日k
  • 周k
  • 月k

相关新闻

更多
  • enGene Holdings GAAP EPS of $0.43

    enGene Holdings press release (ENGN): Q2 GAAP EPS of $0.43. As of April 30, 2026, cash, cash equivalents and marketable securities were $285.2 million providing significant operational flexibility. To...

    06-15 22:12

  • Why Is enGene Therapeutics Stock Falling Friday?

    enGene stock sinks after Phase 2 bladder cancer trial shows durability concerns. Analysts slash price forecasts as the sell-off intensifies.

    05-08 23:34

  • Dow Dips 350 Points; US Foods Posts Downbeat Earnings

    Dow falls over 100 points, S&P 500 and NASDAQ also down. Tech sector up, energy stocks down. US Foods reports lower Q1 earnings and sales. Agilon Health, Aaon, and Rackspace Technology see gains while Entrada, Fastly, and enGene Therapeutics decline. Euro zone and Asian markets mixed.

    05-08 01:39

  • enGene Holdings To Change Its Corporate Name To enGene Therapeutics Effective April 8

    Name change reflects transition towards potential commercial organization in 2027Planned Biologics License Application (BLA) submission for detalimogene in 2H 2026enGene Therapeutics Inc. (formerly, enGene Holdings Inc.)

    04-07 20:11